Letter: body surface area and body muscle parameters may influence adalimumab trough levels

被引：6
作者：
Csontos, A. A. [1 ]
Molnar, A. [2 ]
Miheller, P. [1 ]
机构：
[1] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Sch PhD Studies, Hlth Sci Res, Pathol Sci, H-1085 Budapest, Hungary
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 07期
关键词：
CROHNS-DISEASE PATIENTS; PHARMACOKINETICS;
D O I：
10.1111/apt.13099
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：700 / 700
页数：1
相关论文
共 5 条
[1]   Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients [J].
Bultman, E. ;
de Haar, C. ;
van Liere-Baron, A. ;
Verhoog, H. ;
West, R. L. ;
Kuipers, E. J. ;
Zelinkova, Z. ;
van der Woude, C. Janneke .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) :335-341
[2]   Impact of obesity on the effectiveness of adalimumab for the treatment of psoriasis: a retrospective study of 30 patients in daily practice [J].
Fatima Lafuente-Urrez, Rosario ;
Perez-Pelegay, Julio .
EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (02) :217-223
[3]   Body weight, gender and response to TNF-α blockers in axial spondyloarthritis [J].
Gremese, Elisa ;
Bernardi, Simone ;
Bonazza, Sara ;
Nowik, Marcin ;
Peluso, Giusy ;
Massara, Alfonso ;
Tolusso, Barbara ;
Messuti, Laura ;
Miceli, Maria Concetta ;
Zoli, Angelo ;
Trotta, Francesco ;
Govoni, Marcello ;
Ferraccioli, Gianfranco .
RHEUMATOLOGY, 2014, 53 (05) :875-881
[4]   Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment [J].
Lie, M. R. K. L. ;
Peppelenbosch, M. P. ;
West, R. L. ;
Zelinkova, Z. ;
van der Woude, C. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (10) :1202-1208
[5]   Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Concepts and Lessons for Drug Development [J].
Mould, Diane R. ;
Green, Bruce .
BIODRUGS, 2010, 24 (01) :23-39
1